Transcriptomics

Dataset Information

0

Mevalonate pathway inhibition affects bladder cancer metastasis


ABSTRACT: Metastasis is an important factor affecting the prognosis and survival of bladder cancer (BLCA) patients. Our previous study found that the mevalonate pathway is associated with the migratory ability of BLCA cells, but the exact mechanism is unclear. Here, we found that BLCA patients with mevalonate pathway activation had a poorer prognosis. Inhibition of the mevalonate pathway (FDPS knockdown, simvastatin or zoledronic acid) significantly reduced the migratory ability of BLCA cells. Therefore, we tested the changes of key genes after knocking down the key enzymes of the mevalonate pathway, FDPS and SQLE1, and the transcription factor YY1 in bladder cancer cells using RNA sequencing.

ORGANISM(S): Homo sapiens

PROVIDER: GSE252007 | GEO | 2024/09/08

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-09-09 | PXD048067 |
2018-03-31 | E-MTAB-3263 | biostudies-arrayexpress
2024-09-08 | GSE270394 | GEO
| PRJNA1057080 | ENA
2023-03-10 | GSE225681 | GEO
2023-05-01 | GSE215949 | GEO
2024-06-12 | GSE248825 | GEO
2023-02-06 | GSE151605 | GEO
2010-05-05 | E-GEOD-13424 | biostudies-arrayexpress
2018-10-23 | GSE121558 | GEO